RJT
FLGT icon

Raymond James Trust’s Fulgent Genetics FLGT Stock Holding History

Raymond James Trust’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-337,659
Closed -$17.6M – 1104
2020
Q4 		$17.6M Sell
337,659
-901,291
-73% -$37.7M 0.67% 32
2020
Q3 		$49.6M Buy
1,238,950
+450,599
+57% +$14.1M 2.14% 3
2020
Q2 		$12.6M Buy
788,351
+451,351
+134% +$6.91M 0.61% 42
2020
Q1 		$3.63M Sell
337,000
-82,224
-20% -$1.15M 0.21% 103
2019
Q4 		$5.41M Sell
419,224
-80,776
-16% -$960K 0.26% 91
2019
Q3 		$5.2M Buy
+500,000
New +$4.74M 0.27% 90

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James Trust's FLGT Position: Q1 2021 in Review

Raymond James Trust sold out of Fulgent Genetics (FLGT) in Q1 2021, closing a stake of 337,659 shares — an estimated $17.6M sold.

Raymond James Trust first reported a position in FLGT in Q3 2019 and held it in 6 quarters. The position peaked at $49.6M in Q3 2020. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

  • Raymond James Trust reported no remaining Fulgent Genetics position as of Q1 2021 after selling out during the quarter.
  • Raymond James Trust sold 337,659 Fulgent Genetics shares in Q1 2021, an estimated $17.6M.
  • Raymond James Trust first reported a position in Fulgent Genetics in Q3 2019 and held it in 6 quarters.
  • Raymond James Trust's Fulgent Genetics position peaked at $49.6M in Q3 2020.
  • 256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Raymond James Trust's 13F filing for Q1 2021, filed 3 May 2021.